Abstract
BACKGROUND: Chimeric antigen receptor (CAR) T-cell therapy is a cellular immunotherapy that redirects the killing activity of T cells to fight tumor c......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
